Why Did "Aids Baby" Eliza Jane Really Die?

"Mark Probert" wrote in message
...
JanD wrote:
"Mark Probert" wrote in message
...

Peter Moran wrote:

"Mark Probert" wrote in message
...


john wrote:


http://breakfornews.com/my/modules.p...icle&sid= 259

Christine Maggiore and her husband, Robin Scovill, are challenging the
Los Angeles County Coroner's finding that their three-year-old
daughter Eliza Jane Scovill died from Aids-related pneumonia.

We interview pathologist Dr. Mohammed al-Bayati who has just authored
a report revealing that the child died of anaphylactic reaction to a
prescribed antibiotic, and we speak also Dr. Andrew Maniotis of the
University Illinois at Chicago.

For excellent analysis of al-Bayati's "work" see:

http://tinyurl.com/dam9v

especially this comment by a real pathologist:


A Google search reveals that he is a "pathologist-for-hire", figuring
in many court cases where "alternative" science can get people off. He
was involved in the Yurko case.

I read that. He is NOT a medical doctor, NOT board certified by the ABMS:

Results for Criteria: "al-Bayati"


--------------------------------------------------------------------------------

We are sorry, but there are no entries which match your search criteria,
please try one or more of the following:

While he may be a toxicologist, he is not qualified, IMNSHO, to render an
opinion on diagnosis. The link I provided is to an excellent analysis of
the facts and findings, and, the comment is from a fellow who is, because
he is a coroner.


No need to search for anything EXCEPT the man's name, and correct title.

I had his correct title: PhD in toxicilogy. Not forensic pathology. He is
NOT a coroner.

Dr. Mohammed al-Bayati


Proving, Mark Probert is a BLATANT LIAR.

Where is the lie? Do remember to specifically point it out.

TWO LINES UP, IDIOT!!!!

I ALREADY DID!

http://www.justiceforej.com/

Dr. Mohammed Al-Bayati is a respected pathologist (PhD) and a dual board
certified toxicologist with over twenty-five years experience and over
forty articles published in the scientific and medical literature.

So? As was pointed out, and as you found, but chose to ignore, he is a
hired gun witness.

I noticed YOUR LIE!!!!!



http://www.ourcivilisation.com/aids/....htm#Education

Education And Board Certifications

I. Human Pathology, Toxicology, Immunology, and Biochmestry

Ph.D. 1989 Comparative Pathology. University of California Davis, Davis,
California. Subject of studies: Human pathology, toxicology,
pharmacology, medical immunology, medical biochemistry, analytical
toxicology, environmental toxicology, and experimental toxicology.
Dissertation: Toxicokinetics and Toxicity of Vanadate

DABT 1994 Diplomate, American Board of Toxicology

II. Veterinary Pathology, Toxicology, Immunology, and Endocrinology

DABVT 1996 Diplomate, American Board of Veterinary Toxicology

*Veterinary Pathology* hmmm....do dogs, cats and kittens get HIV/AIDS?

I. *Human Pathology*, Toxicology, Immunology, and Biochmestry

The FIRST ONE LISTED! IDIOT!

M.V.Sc. 1978 Veterinary sciences. University of Cairo, College of
Veterinary Medicine, Cairo, Egypt Subject of studies: Veterinary
pathology and physiology. Dissertation: Histopathological and
histochemical changes in the adrenal glands of the Egyptian Buffalo with
follicular cysts and inactive ovaries.

BVMS 1975 University of Baghdad, College of Veterinary Medicine, Baghdad,
Iraq.

Interestingly, no PhD is mentioned there....

Ph.D. 1989 Comparative Pathology. University of California Davis, Davis,
California. Subject of studies: Human pathology, toxicology,
pharmacology, medical immunology, medical biochemistry, analytical
toxicology, environmental toxicology, and experimental toxicology.
Dissertation: Toxicokinetics and Toxicity of Vanadate

SECOND LISTED, IDIOT!!!

--------------------------------------------------------------------------------
Personal Information
United States Citizen Languages: English and Arabic: speak, read, and
write fluently
--------------------------------------------------------------------------------
Qualifications In Toxicology And Biomedical Sciences
a.. Expertise in human, veterinary, experimental, and environmental
toxicology and pathology, including: diagnostic toxicology (exposure of
human and animals to pesticides, herbicides, heavy metals, organic
solvents, biotoxins, therapeutic drugs, industrial chemicals, and
radiation), evaluating human and veterinary clinical data and
pathological lesions in tissues, and experience in the kinetics of
toxicants in human and animals.
b.. Worked with various communities and health care providers to
identify causes of illness resulting from environmental exposure to
pesticides, herbicides and other xenobiotics, and medications
c.. Expertise in writing medical opinions in support of legal claims
and obtaining a proper diagnosis in cases related to exposure of people
and animals to toxic agents, therapeutic drugs, and radiation.
d.. Served as Expert Witness on many cases involving the exposure of
people to chemicals at workplace. In these cases, I identified the
cause(s) of illnesses and provided the treating physicians and the
attorneys with reports describing my findings.
e.. Over 15 years experience of directing, designing, and implementing
in vivo and in vitro toxicological studies according to Good Laboratory
Practice Guidelines. Wrote protocols, standard operating procedures, and
quality assurance plan for toxicity and toxicokinetic studies. Developed
methods to evaluate the effects of toxicants and drugs on biological
systems (in vitro and in vivo systems).
f.. Developed protocols for and interpreted results of Gas
Chromatography and High Performance Liquid Chromatography, Liquid
Scintillation Counter and Radiomatic Detector, Spectrophotometer
(UV-Visible), Biological Sample Oxidizer, and other analytical systems.
g.. Performed Enzyme assays in serum and tissues.
h.. Perform assays in serum and tissues to measure heavy metals and
pesticides.
i.. Used radioisotopes (14C, 3H, 32P, and others) to study drugs and
xenobiotics metabolism in vivo and/or in vitro.
j.. Collected, inspected, and analyzed numerical data derived from
experimental studies.

--------------------------------------------------------------------------------
Teaching Experience
a.. Instructed and supervised undergraduate, graduate students,
laboratory assistants, and laboratory technicians in the areas of general
toxicology, systemic toxicology, toxicologic pathology, analytical
toxicology.
Writing Research Grants, Contracts And Supervising Experience
a.. Served as Principal and Co-Principal Investigator in many funded
studies using animal models to evaluate the toxicokinetics and the
toxicity of xenobiotics, pesticides and drugs. Maintain budgets, write
budget reports and keep projects running within the predicted time
frames. Supervised research activities in toxicology facilities for about
15 years. The following is a list of previously funded projects
a.. Project Title: Quantitative Evaluation of Serum Chemistry,
Hematology and Pathological Parameters in Dog, Sheep, and Pig Exposed To
Whole Body Irradiation. Agency: AMGEN Pharmaceutical Inc. Thousand Oaks,
CA 91320 Duration: 30 months (1993-1995) Amount: $254,778, Position: PI
b.. Project Title: Improved Models of Risk for Exposure to Organic
Toxicant and Carcinogens. Agency: United States Environmental Protection
Agency Duration:48 months (1990-1995) Amount: $980,000 Project Role:
Co-PI
c.. Project Title: Improved Models of Risk for Exposure to Organic
Toxicant. Agency: United States Environmental Protection Agency
Duration:36 months (1987-1990) Amount: $240,000 Project Role: Co-PI
d.. Project Title: Dermal Absorption of Methanol and
Gasoline/Methanol Mixtures. Agency: California Air Resources Board
Duration:18 months (7/90-12/91) Amount:$84,000Project Role: Co-PI
e.. Project Title: Toxicity of the Inhaled Dimethylselenide in Adult
Rat. Agency: University of California, Riverside Duration: 12 months
(07/87-07/88) Amount: $70,000 Position: Co-PI
f.. Project Title: Inhalation Uptake of Xenobiotic Vapors in People.
Agency: California Air Resources Board; Contract No. A5-155-33 Duration:
18 months (1986-1987) Amount: $150,000 Position: Investigator
g.. Project Title: Effects of Airborne Particulate Matter. Agency:
California Air Resources Board; Contract No. A4-133-33 Duration: 24
months (1985-1987) Amount: $250,000 Position: Investigator
h.. Project Title: Gastrointestinal Tract Uptake of Benzene in
Drinking Water, and Consequent Tissue and Fetal Retention. Agency: Toxic
Substance Research and Teaching Program, University of California, Davis
Duration: 12 months (1986-1987) Amount: $50,000 Position: Co-PI
i.. Project Title: Inhalation Uptake of Xenobiotic Vapors at Trace
Levels. Agency: California Air Resources Board; Contract No. A3-132-33
Duration: 18 months (1984-1986) Amount: $140,000 Position: Investigator
j.. Project Title: Toxicity and Toxicokinetics of Vanadium in
Rodents. Agency: United States Department of Energy Duration: 72 months
(1981-1987) Position: Co-PI
k.. Project Title: Studies of Biological Behavior of Pu-241 and
Am-241 in Rat, Dog, and Primate. Agency: United States Department of
Energy Duration: 72 months (1980-1986) Position: Investigator
l.. Project Title: Respiratory Tract Deposition of Inhaled Aerosols
in Small Rodents. Agency: United States Environmental Protection Agency
Duration: 60 months (1980-1985) Amount:$500,000 Position: Investigator
Professional Experience And Service

2001-Present - Forensic adviser for the defence in the Yurko court case.

1997-Present President, Toxicologist and Pathologist Toxi-Health
International 150 Bloom Dr., Dixon, CA 95620

March, 2000- August, 2001 Department of Molecular Biology Research
project to test the antifibrotic effects of Pirfenidone in rat-V-Kidney
Fibrosis model

1996-June, 1997 Toxicology Information Specialist and Outreach
Coordinator, Center for Environmental Health Sciences. University of
California Davis, Davis, CA 95616

1991-1996 Assistant Research Toxicologist. Institute of Toxicology &
Environmental Health University of California Davis, Davis, CA 95616

1991-1996 Member of Review Board Bulletin of Environmental Contamination
and Toxicology.

1991-1992 Served as faculty advisor for 72 undergraduate students of
various academic disciplines. (5-10 hours per week) University of
California Davis, Davis, CA 95616

1986-1990 Staff Research Associate IV, Toxicologist Institute of
Toxicology & Environmental Health University of California Davis, Davis,
CA 95616

1979-1986 Staff Research Associate II, Toxicologist Institute of
Toxicology and Environmental Health University of California Davis,
Davis, CA 95616


--------------------------------------------------------------------------------
Memberships & Associations
Society of Toxicology
American Board of Toxicology
American Board of Veterinary Toxicology
American Association for the Advancement of Science
American Chemical Society
American Lung Association
Editorial Board, Bulletin of Environmental Contamination and
Toxicology

Memberships do not prove qualifications, just that a fee was paid.

I do not see any evidence that he is a forensic pathologist as the person
I quoted is.

D U H!!!!!

--------------------------------------------------------------------------------
Patent
U.S. PATENT NUMBER: 5,686,217 PATENT DATE: NOVEMBER 11, 1997 USE OF
BIOMARKERS IN SALIVA TO EVALUATE THE TOXICITY OF AGENTS AND THE FUNCTIONS
OF TISSUES IN BOTH BIOMEDICAL AND ENVIRONMENTAL ALLPLICATIONS.
--------------------------------------------------------------------------------
Articles

1982 Wei, C. I., M. A. Al-Bayati, M. R. Culbertson, L. S. Rosenblatt, and
L. D. Hansen. Acute toxicity of ammonium metavanadate in mice. Journal of
Toxicology and Environmental Health 10: 673-687.

1984 Raabe, O. G., M. A. Al-Bayati, F. Gielow, J. P. Schreider, and N.
J.Parks. Studies of the distribution in beagles of Pu-241 after
intratracheal instillation of ultrafine insoluble particles. Health
Physics 47:210.

1987 Knaak, J. B., J. Schreider, O. G. Raabe, M. A.Al-Bayati and B. W.
Wilson. The percutaneous absorption of oxidazan in the adult female rat.
In: Pesticide Science and Biotechnology. Greenhalgn, R. and Roberts, T.
R. (eds.), Blackwell Scientific Publications, pp. 545-548.

1987 Knaak, J. B., M. A. Al-Bayati, F. Gielow, and O. G. Raabe. Safety
related to exposu Dermal dose-red cell cholinesterase response curves
for Ethoprop and Mocap 6 EC. Bulletin of Environmental Contamination
Toxicology 38: 834-839, Springer-Verlag New York Inc.

l988 Raabe, O. G., M. A. Al-Bayati, S. Teague, and A. Rasolt. Regional
deposition of inhaled monodisperse coarse and fine particles in small
laboratory animals. Annals of Occupational Hygiene 32(1): 53-63.

1989 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, J. L. Wiedmann, J. W.
Pensyl, J. H. Ross, A. P. Leber, and P. Jones. Mixer-loader-applicator
exposure and percutaneous absorption studies involving EPTC herbicide.
Chapter 22. In: Biological Monitoring for Pesticide Exposu
Measurement, Estimation,and Risk Reduction, Wang, R. G. M., C. A.
Franklin, R. C. Honeycut, and J. C. Reinert (eds.), American Chemical
Society, Washington, DC., pp. 288-303.

1989 Al-Bayati, M. A., S. N. Giri, O. G. Raabe, L. S. Rosenblatt, and M.
Shifrine. Time and dose-response study of the effects of vanadate on
rats: Morphological and Biochemical changes in organs. Journal of
Environmental Pathology, Toxicology and Oncology 9(5): 435-455.

1990 Al-Bayati, M. A., S. N. Giri and O. G. Raabe. Time and dose-response
study of the effects of vanadate on rats: Changes in blood cells and
serum elements. Journal of Environmental Pathology, Toxicology, and
Oncology 10(4-5): 206-213.

1990 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. In
vivo percutaneous absorption studies in rat: Pharmacokinetics and
modeling of isofenphos absorption. In: Prediction of Percutaneous
Penetration: Methods, Measurements, and Modelling. Scott, R. C. (ed), IBC
Technical, England.

1991 Al-Bayati, M. A., O. G. Raabe, S. N. Giri, and J. B. Knaak.
Distribution of vanadate in rat following subcutaneous and oral exposure.
Journal of the American College of Toxicology 10(2): 233-241.

1992 Al-Bayati, M. A., M. R. Culbertson, J. P. Schreider, L. S.
Rosenblatt, and O. G. Raabe. The lymphotoxic action of vanadate. Journal
of Environmental Pathology, Toxicology, and Oncology, Volume II, No.2.

1992 Knaak, J. B., M. A. Al-Bayati and O. G. Raabe. Physiologically-based
pharmacokinetics modeling to predict tissue dose and cholinesterase
inhibition in workers exposed to organophosphorus and carbamate
pesticides. In: Health Risk Assessment Through Dermal and Inhalation
Exposure and Absorption of Toxicant, G.M. Wang, J.B. Knaak, and HI
Maibach (eds.). CRC Press, Boca Raton, FL.

1992 Mohammed A. Al-Bayati, Otto G. Raabe, and Stephen V. Teague. Effect
of inhaled dimethylselenide in the Fischer 344 male rat. Journal of
Toxicology and Environmental Health 37:549-557.

1993 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, J.N. Blancato.
Development of in vitro Vmax and Km Values for the metabolism of
isofenphos by P-450 liver enzymes in animals and human. Toxicology and
Applied Pharmacology 120:106-113.

1993 Sidney M. Gospe, Jr. and Al-Bayati, M. A. Comparison of oral and
inhalation exposures to toluene. American College of Toxicology, 13(1):
21-32.

1994 Raabe, O. G., D. W. Wilson, M. A. Al-Bayati, W. J. Hornof and L. S.
Rosenblatt. Biological effects of inhaled pollutant aerosols. Ann. Occup.
Hyg. Vol. 38 Supplement 1. pp. 323-330.

1994 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato.
Prediction of anticholinesterase activity and urinary metabolites of
isofenphos: Use of apercutaneous physiologically based
pharmacokinetic-physiologically based pharmacodynamic model. In:
Biomarkers of Human Exposure to Pesticides, Chapter 17, Saleh, MA,
Blancato, JN, and Nauman, CH (eds.). American Chemical Society Symposium
Series 542, Washington, D.C.

1995 Knaak, J. B., M. A. Al-Bayati, and O. G. Raabe. Development of
partition coefficients, Vmax and Km values, and allometric relationships.
Toxicology letters 79, 87-98.

1995 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. Use
of a multiple pathway and multiroute PBPK model for predicting OP
toxicity: In American Chemical Society Symposium: Field Application of
Biomarkers for Agrochemicals. April 3-7, Anaheim, CA.

1996 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. Use
of a multiple pathway and multiroute PBPK model for predicting OP
toxicity: Field Application of Biomarkers for Agrochemicals. In American
Chemical Society Symposium Series 643, Washington, D.C., pp.206-228

1996 Raabe, O.G. and Al-Bayati, M.A. Distribution and retention of
inhaled vanadium on inert airborne particles. Ann. Occup. Hyg., Vol.41,
supplement 1.

1999Mohammed Ali Al-Bayati. Get All The Facts: HIV Does Not Cause AIDS.
Toxi-Health International, Dixon, CA [ISBN 0-9673536-0-2]

2002 Mohammed Ali Al-Bayati. HIV Does Not Cause AIDS, letter to the
editor of The British Medical Journal. January 30, 2002

2002 Al-Bayati, MA. AIDS in Africa is Caused by Starvation and
Medications. The British Medical Journal, March 7, 2002

2002 Al-Bayati, MA. Keep The Dentist Working: HIV Does Not Cause AIDS.
The British Medical Journal March 15, 2002 .

2002 Al-Bayati, MA. Stop Giving People Toxic Drugs: HIV Does Not Cause
AIDS. The British Medical Journal, April 4, 2002.

2002 Al-Bayati, MA. Do Not Give Your Soldiers Toxic Drugs: HIV Does Not
Cause AIDS. The British Medical Journal, April 4, 2002.

2002 Mohammed Ali Al-Bayati, Yan Xie, F. Charles Mohr, solomon B.
Margolin, Shri N. Giri. Effect of Pirfenidone Aganist Vanadate-Induced
Kidney Fibrosis in Rats. Biochemical Pharmacology ( In Press).


--------------------------------------------------------------------------------
Reports

1987 Raabe and Al-Bayati, M.A. Gastrointetinal-tract Uptake of Benzene in
drinking water in rats. Submitted to the University of California Toxic
Substance and Teaching Program, Davis, CA.

1988 Raabe, O.G. Knaak, J.B. , Al-Bayati, M.A., Uyeminami, D., and
Gielow, F. Development of Multiple Route Compound Pharmacokinetic Models:
Development of a physiological Pharmacokinetic Model for an
Organophosphate: isofenphos. Submitted to Exposure Assessment group,
USEPA, Wahington, DC. September 20, 1988.

1988 Raabe, O.G., Al-Bayati, M.A., Gielow, F., Teague, S., and Uyeminami.
Inhalation Uptake of Xenobiotic Vapors by People. Submitted to the
Biological effects Research Section, California Air Resources Board,
SACRAMENTO, California (CARB Contract NO. A5-155-33). March 1988.

1992 Raabe, O.G., Al-Bayati, M.A., Shulec, P.D., Gielow, F., Uyeminami,
and N. Shimasaki. Dermal Absorption of Methanol and methanol/Gasoline
Mixtures. Submitted to the Biological effects Research Section,
california Air Resources Board, Sacramento, California (CARB Contract NO.
A933-186). December 1992.


--------------------------------------------------------------------------------
Presentations And Abstracts
1978 Shehata, H. A., A. A. Hegazy, and M. A. Al-Bayati. Histopathological
and histochemical studies in adrenal gland of buffalo in case of cystic
and inactive ovaries. X World Congress of Buiatrics, Aug. 16-19. Mexico.
1984 Raabe, O. G., M. A. Al-Bayati, F. Gielow, J. P. Schreider, and N.
J.Parks. Studies of the distribution in beagles after intratracheal
instillation as ultrafine insoluble particles. Presented at the Health
Physics Society Annual Meeting, June. New Orleans, LA.

1985 Raabe, O. G., M. A. Al-Bayati, and F. Gielow. Metabolism of Pu-241
in beagles and non-human primates after intratracheal instillation of
ultrafine insoluble particles. Presented at the Health Physics Society
Annual Meeting, May. Chicago, IL,.

1988 Al-Bayati, M. A., S. N. Giri, O. G. Raabe, M. Shifrine, and L.
S.Rosenblatt. Chronic renal toxicity of vanadium in rat. FASEB Meeting ,
May 1. Las Vegas, Nevada, USA,.

1988 Knaak, J. B., M. A. Al-Bayati, and O. G. Raabe. Study on the
pharmacokinetics and toxicity of isofenphos in rat. FASEB Meeting, May 1.
Las Vegas, Nevada, USA,.

1990 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato. In
vitro metabolism of isofenphos by human and animal liver. American
Chemical Society Meeting, April 22-27. Boston, MA.

1992 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato.
Prediction of anticholinesterase activity and urinary metabolites of
isofenphos: Use of a percutaneous physiologically based pharmacokinetic-
physiologically based pharmacodynamic model. American Chemical Society
Meeting, August 23-28. Washington, D.C.

1993 Knaak, J. B., M. A. Al-Bayati, O. G. Raabe, and J. N. Blancato.
Development of in vitro Vmax and Km values for the metabolism of
isofenphos by P-450 liver enzymes in animals and human. Society of
Toxicology 32nd Annual Meeting, March 14-18, New Orleans, Louisiana.

1994 M. A. Al-Bayati, J.B. Knaak, O. G. Raabe, and J. N. Blancato. The
effects of enzyme inducers and inhibitors on the metabolism of isofenphos
by rat liver P450 enzymes. Society of Toxicology 33th Annual Meeting,
March 13-18, Dallas, Texas.

1995 M. A. Al-Bayati, J.B. Knaak, O. G. Raabe, and J. N. Blancato.
Toxicity and Pharmacokinetics of Isofenphos in Male Guinea Pig. Society
of Toxicology 34th Annual Meeting, March 5-9. Baltimore, Maryland.

2001 Al-Bayati MA,Xie Y,Mohr CF,Margolin SB,Giri SN. Amelioration of
Vanadium Induced Kidney Fibrosis by Pirfenidone in Rats. Society of
Toxicology 40 th AnnualMeeting, March 25-30. San Francisco, California.


nope, No PhD listed....

Too bad, you are sooooooooooooo confused, YOU can't even remember what YOU
posted, IDIOT!!!

*I had his correct title: PhD in toxicilogy* (sic)

No wonder you never won a case in court!!